David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
David McIntosh, Founder and Chair of United Plasma Action, shared a post on LinkedIn:
“Vital Plasma Derived Medicines: The Anomalous UK Scene
In the context of recent news of the renewed availability of plasma from UK citizens, and former UK residents, for pharmaceutical use in vital medicines production, this reminder may be apposite.
Unlike other National Regulators, the UK Authority, the MHRA, is apparently still haunted by phantom fears of the 20th Century Mad Cow Disease – leading it to maintain its utterly unwarranted prohibition of the use of UK donors’ plasma for the manufacture of a dozen or so vital medicines for which it is a perfectly suitable raw material.
This misguided behaviour is not only enforcing a most unfortunate waste of precious components of UK donors’ plasma – and costing the NHS money in the passing – it is also exacerbating severe global shortages of many of these life-saving medicines.
We UK donors may well ask – ‘why?’
Indeed, some of us have been asking this question for some years now.
Answer comes there none …
What do other donors and fellow LinkedIners think about this ?”
Find more posts featuring David McIntosh on Hemostasis Today.
-
May 18, 2026, 16:35Abdurrahmaan Ali Suei Elbuzidi: What is the Optimal Anticoagulation Monitoring Target in ECMO?
-
May 18, 2026, 16:34Serah N. Gathu: Gaining Valuable Updates on ACS Management at the Africa STEMI Conference
-
May 18, 2026, 16:34Mahmoud Alhariri: Apixaban in Hemodialysis-Treated Kidney Failure With Newly Diagnosed AF
-
May 18, 2026, 16:33Dimitrios Kontothanassis: The Role of Thermal Ablation in GSV Reflux Treatment – LIVE 2026
-
May 18, 2026, 16:32Michael Lichardi: New Publication on Complex Anticoagulation Management in Critical Care
-
May 18, 2026, 16:28Reza Shojaei: The Global Plasma-to-Ig Supply Chain
-
May 18, 2026, 16:01Abdul Mannan: The Hardest Conversations in Myelofibrosis
-
May 18, 2026, 15:57Bridging Innovation and Access at the WFH 2026 World Congress – South African Haemophilia Foundation
-
May 18, 2026, 15:55Pierre François Sabouret: Network Meta-Analysis of Antithrombotic Therapy in Ischemic Stroke Patients